MaxCyte VLX Large Scale Transfection System

The MaxCyte VLX^® Scalable Transfection System is a bench-top, easy-to-use instrument specifically designed for extremely large volume cell-engineering. Using proprietary Flow Electroporation™ Technology, the MaxCyte VLX can transfect up to 200 billion cells in less than 30 minutes – 10x the capacity of the MaxCyte STX^®. This cGMP-compliant system offers a clear regulatory pathway and is ideal for the rapid production of recombinant proteins, monoclonal antibodies, viral vectors, vaccines and VLPs from R&D through cGMP pilots and commercial manufacturing.

High-Performance

• Cell viabilities >90% for commonly used cell types
• Transfection efficiencies >90%
• Computer-controlled system for day-to-day and user-to-user consistency

Flexible

• Engineer cell lines commonly used for protein and viral vector production
• Single animal component-free electroporation buffer for all cell types
• Pre-loaded library of validated, cell specific protocols for plug-and-play transfection

Scalable

• Seamless migration from the MaxCyte STX that requires no re-optimization
• 5 x 10⁶ to 7 x 10⁸ cells in seconds
• Up to 2 x 10¹¹ cells in <30 minutes

Regulatory Pathway

• Sterile, single use processing assemblies
• Closed, cGMP-compliant, ISO-certified and CE-marked instruments
• Supported by FDA master file